Official links
- Prospectus
- Allotment statusAllotment is the decision of who gets shares after the issue closes. Basis of allotment, in the glossary
How to apply
Use UPI and ASBA. The guide covers the close, allotment, and the T+3 listing.
Open the guideRelated guides
Anthem Biosciences IPO listing price
Listed at ₹723.05 on 21 Jul 2025.
- Listing price
- ₹723.05
- Last pre-listing GMPGMP means grey market premium. It is an unofficial price before listing, not the issue price.
- ₹179 (checked 21 Jul 2025, 10:00 am IST). Unofficial
- Close on listing day
- ₹730.35
The listing gain versus the issue price of ₹570 is ₹153.05 above it (26.85%).
The grey market was ₹179, which pointed to ₹749. The listing was ₹25.95 below that.
The grey market premium is unofficial.
Anthem Biosciences IPO subscription status
Subscribed 67.42× overall. Final, as of 16 Jul 5 pm IST.
Total
67.42×
Anthem Biosciences IPO lot size and application limits
Application amounts calculated at the upper price band (cap price of ₹570). Retail applications are capped at ₹2,00,000 by SEBI rules.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 lot | 26 shares | ₹14,820 |
| Retail (Max) | 13 lots | 338 shares | ₹1,92,660 |
| Small HNI (sNII Min) | 14 lots | 364 shares | ₹2,07,480 |
| Small HNI (sNII Max) | 67 lots | 1,742 shares | ₹9,92,940 |
| Big HNI (bNII Min) | 68 lots | 1,768 shares | ₹10,07,760 |
Dates
Opens
14 Jul 2025
Closes
16 Jul 2025
AllotmentAllotment is the decision of who gets shares after the issue closes. Basis of allotment, in the glossary
17 Jul 2025
Refunds
18 Jul 2025
Demat credit
18 Jul 2025
Listing
21 Jul 2025
About this company and offer
Anthem Biosciences Ltd. IPO is listed. It opened on 14 Jul 2025 and closed on 16 Jul 2025. It listed on 21 Jul 2025. The price band is ₹540 to ₹570. One lot is 26 shares, and the minimum amount is ₹14,820 for 1 lot. The issue size is ₹3,395 crore, with a fresh issue of ₹0 crore and an offer for sale of ₹3,395 crore. In FY25, revenue from operations was ₹1,930.29 crore and profit after tax was ₹451.26 crore. Revenue from operations was up 30.2% from ₹1,483.07 crore in FY24. Profit after tax was up 22.9% from ₹367.31 crore in FY24.
The grey market premium shown for Anthem Biosciences Ltd. is ₹179. Grey market premium is unofficial and not a guarantee of listing price.
The total subscription for Anthem Biosciences Ltd. is 67.42 times.
Anthem Biosciences Ltd. listed at ₹723.05.
Anthem Biosciences is a contract research, development and manufacturing company that works with pharmaceutical and biotechnology clients.
Promoters
Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa and Ishaan Bhardwaj
Reservation
- Retail
- 35%
- Large bidsNII means a bid bigger than the retail limit, and not from a big institution. How allotment works
- 15%
- Big fundsQIB means a big institution, such as a mutual fund or a bank. How allotment works
- 50%
Financials
₹ crore, for the last three reported years.
Revenue from operations and profit
Each chart has its own scale. Amounts are in ₹ crore.
Revenue from operations
| Year | Revenue from operations |
|---|---|
| FY23 | ₹1,134 cr |
| FY24 | ₹1,483 cr |
| FY25 | ₹1,930 cr |
Profit after tax
| Year | Profit after tax |
|---|---|
| FY23 | ₹385 cr |
| FY24 | ₹367 cr |
| FY25 | ₹451 cr |
| Year | Revenue from operations | Profit |
|---|---|---|
| FY23 | ₹1,133.99 crore | ₹385.19 crore |
| FY24 | ₹1,483.07 crore | ₹367.31 crore |
| FY25 | ₹1,930.29 crore | ₹451.26 crore |
Net worth
₹ crore, for each year that reports net worth.
| Year | Net worth |
|---|---|
| FY23 | ₹1,740.67 crore |
| FY24 | ₹1,924.66 crore |
| FY25 | ₹2,409.86 crore |
| Year | Net worth |
|---|---|
| FY23 | ₹1,740.67 crore |
| FY24 | ₹1,924.66 crore |
| FY25 | ₹2,409.86 crore |
| Year | Revenue from operations | PAT | Net worth | Assets | Borrowings |
|---|---|---|---|---|---|
| FY23 | 1,133.99 | 385.19 | 1,740.67 | — | — |
| FY24 | 1,483.07 | 367.31 | 1,924.66 | — | — |
| FY25 | 1,930.29 | 451.26 | 2,409.86 | — | — |
Issue structure
Offer for sale
₹3,395 crore Fresh issue ₹0 crore
Reservation
Share kept for each group. The percents are the published figures.
| Part | Amount |
|---|---|
| Retail | 35% |
| Large bids | 15% |
| Big funds | 50% |
| Part | Amount |
|---|---|
| Retail | 35% |
| Large bids | 15% |
| Big funds | 50% |
Issue
- Face value
- ₹2
- Fresh issue
- ₹0 crore
- Offer for saleOFS means offer for sale. Existing owners are selling shares. The company does not get that money.
- ₹3,395 crore
- Exchanges
- BSE, NSE
- Registrar
- Kfin Technologies Ltd.
Frequently asked questions
What is the Anthem Biosciences Ltd. IPO date?
It opened on 14 Jul 2025 and closed on 16 Jul 2025.
What is the price band of Anthem Biosciences Ltd. IPO?
The price band is ₹540 to ₹570. One lot is 26 shares, and the minimum amount is ₹14,820 for 1 lot.
What is the last GMP of Anthem Biosciences Ltd. IPO?
The unofficial grey market premium is ₹179 as of 21 Jul 2025, 10:00 am IST. The grey market is unofficial.
How do I check Anthem Biosciences Ltd. IPO allotment status?
Allotment was on 17 Jul 2025. You can check allotment status online using the registrar portal linked on this page.
How many times was Anthem Biosciences Ltd. IPO subscribed?
Total subscription is 67.42 times, checked 16 Jul 2025, 5:00 pm IST.
What is the Anthem Biosciences Ltd. IPO listing price?
The listing price was ₹723.05 with a listing gain of 26.85% against the upper band of ₹570.
What is the issue size of Anthem Biosciences Ltd. IPO?
The issue size is ₹3,395 crore, with a fresh issue of ₹0 crore and an offer for sale of ₹3,395 crore.
This page is a calendar of dates and prices. It is not a recommendation to apply.